Articles & Video
Building a global regulatory strategy
This whitepaper identifies the key factors, requirements and challenges affecting applying for marketing authorisation in different world regions.
Pharma and Medical Device Regulations Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the hottest topics in pharma, biotech and medical device regulatory affairs and law with one simple registration.
Life Sciences in 2030 Survey: Complete to win a 2-day conference pass
We are a conducting a huge survey of life sciences professionals around the world on how the industry will look by 2030. Complete it here to get early access to the final report.
The use of Real World Evidence and AI within the regulatory landscape
This whitepaper explores how the pharmaceutical industry can leverage Real World Evidence and AI in regulatory affairs.
The 2020 Outlook for Europe
Discover insights and gain helpful advice in this curated article pack from Informa Pharma Intelligence on biotech, regulations, pharma, and financial investment in Europe and the United Kingdom.
Global Pharmaceutical Regulatory Affairs State of the Industry Report 2019
In early 2019, we surveyed the perspectives of pharmaceutical regulatory professionals around the world. This report reveals insights into the industry's greatest challenges.
China's changing pharmaceutical regulatory approval landscape
China has recently taken unprecedented steps to improve its healthcare and regulatory system. This whitepaper examines the recent changes and what opportunities and challenges they bring.
Regulatory challenges and strategies for oligonucleotide, peptide and mRNA therapeutics - WHITEPAPER
We explore the regulatory challenges and successful approval strategies for oligonucleotide, peptide and mRNA therapeutics.
Regulatory development opportunities for global harmonisation of eSubmissions
What's delaying the global harmonisation of eSubmissions for market authorisation? This whitepaper examines the latest developments and ongoing challenges.
Digital Health: Advancing innovation through technology and strategic partnerships
Insights from investors, biopharma leaders and digital health executives on how to navigate the digital health sector as it transforms every aspect of the pharmaceutical value chain.
The regulatory hurdles to microbiome therapeutic commercial success
Human microbiome therapeutic commercial success hinges on overcoming regulatory hurdles - here 8 industry experts look at how.